<DOC>
	<DOCNO>NCT02377440</DOCNO>
	<brief_summary>The investigator hypothesize old person ( â‰¥45 year ) treat ACEI HTN control : ) improve status bone turnover ( decreased P1NP CTX ) , ii ) decrease level RANKL RANKL/OPG , compare treat ACEI use RAS-related medication</brief_summary>
	<brief_title>Effects ACEI Bone Turnover</brief_title>
	<detailed_description />
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<criteria>least 45 year age diagnosis ( either new uncontrolled ) HTN need new medication HTN control able consent ( medial issue impair judgment consent base clinical provider ' judgment ) . young 45 year age diagnosis metabolic bone disease diagnosis osteoporosis use medication treat osteoporosis diagnosis diabetes mellitus , renal insufficiency , cancer history allergy ACEI ARB , 6 ) history use ACEI ARB .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>ACE inhibitor</keyword>
</DOC>